资讯

HeartBeam’s ECG technology shows promise in study for arrhythmia diagnosis
HeartBeam rolled out an application for its 12-lead ECG synthesis software to the FDA, based on the data from the study.
MassDevice2 天
HeartBeam 12-lead ECG meeds study endpoints
HeartBeam (Nasdaq:BEAT) today announced that a study of its synthesized 12-lead electrocardiogram (ECG) met its clinical ...
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12 ...
HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology ...